Changes in global gene expression induced by NOR1 over-expression in HepG2 cells

Progress in Biochemistry and Biophysics

Volumn 35, Issue 4, 2008, Pages 457-464

  Li, Deng Qing ^a,b   Tang, Hua ^a   Gui, Rong ^b   Nie, Xin Min ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

cDNA microarray; Hepatoma; NOR1; Quantitative real time PCR

Indexed keywords

EID: 48449084521     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Chinese source
2. Nie X M, Zhou M, Tang K, et al. Chinese Journal of Biochemistry and Molecular Biology, 2003, 19(14): 423-428
3. Chinese source
4. Nie X M, Gui R, Li D Q, et al. Prog Biochem Biophys, 2005, 32(8): 777-780
5. Chinese source
6. Fu J F, Li D Q, Gui R, et al. Chinese Journal of Laboratory Medicine, 2005, 28(12): 1267-1269
7. 1 nasopharyngeal carcinoma cell line. J Cancer Res Clin Oncol, 2003, 129(7): 410-414
8. Scaplehorn N, Holmstrom A, Moreau V, et al. Grb2 and Nck act cooperatively to promote actin-based motility of vaccinia virus. Curr Biol, 2002, 12(9): 740-745
9. Carlier M F, Le Clainche C, Wiesner S, et al. Actin-based motility: from molecules to movement. Biol Essays, 2003, 25(4): 336-345
10. Chinese source
11. Chen Y S, Shi J Q. Molecular Biology of Neoplastic Cell. Beijing: People's Military Medical Press, 2004. 274-276
12. Jones N, Master Z, Jones J, et al. Identification of Tek/Tie2 binding partners. Binding to a multifunctional docking site mediates cell survival and migration. J Biol Chem, 1999, 274(43): 30896-30905
13. Stein E, Cerretti D P, Daniel T O, et al. Ligand activation of ELK receptor tyrosine kinase promotes its association with Grb10 and Grb2 in vascular endothelial cells. J Biol Chem, 1996, 271 (38): 23588-23593
14. Tammela T, Enholm B, Alitalo K, et al. The biology of vascular endothelial growth factors. Cardiovasc Res, 2005, 65(3): 550-563
15. Rosen E M, Lamszus K, Laterra J, et al. HGF/SF in angiogenesis. Ciba Found Symp, 1997, 212(1): 215-226
16. Atabey N, Gao Y, Yao Z J, et al. Potent blockade of hepatocyte growth factor-stimulated cell motility, matrix invasion and branching morphogenesis by antagonists of Grb2 Src homology 2 domain interactions. J Biol Chem, 2001, 276(17): 14308-14314
17. Soriano J V, Liu N, Gao Y, et al. Inhibition of angiogenesis by growth factor receptor bound protein 2-Src homology 2 domain bound antagonists. Mol Cancer Ther, 2004, 3(10): 1289-1299
18. Chinese source
19. Li W M, Chen W B. Journal of Sichuan University(Medical Sciences Edition), 2003, 34(3): 465-467
20. Tassi E, Henke R T, Bowden E T, et al. Expression of a fibroblast growth factor-binding protein during the development of adenocarcinoma of the pancreas and colon. Cancer Res, 2006, 66(2): 1191-1198
21. Cross S S, Yang Z, Brown N J, et al. Osteoprotegerin (OPG)-a potential new role in the regulation of endothelial cell phenotype and tumour angiogenesis. Int J Cancer, 2006, 118(8): 1901-1908
22. Mizutani Y, Matsubara H, Yamamoto K, et al. Prognostic significance of serum osteoprotegerin levels in patients with bladder carcinoma. Cancer, 2004, 101(8): 1794-1802
23. Holen I, Croucher P I, Hamdy F C, et al. Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells. Cancer Res, 2002, 62 (6): 1619-1623
24. Chinese source
25. Zhao J N, Wang J, Liu Y S, et al. Chinese Journal of Neuromedicine, 2007, 6(3): 282-285
26. Zhang J, Fu M, Myles D, et al. PDGF induces osteoprotegerin expression in vascular smooth muscle cells by multiple signal pathways. FEBS Lett, 2002, 521(1-3): 180-184